Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Marks

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Molecular Therapy. Methods & Clinical Development|August 11, 2021
Evidence generation and reproducibility in cell and gene therapy research: A call to actionMohamed Abou-El-Enein, Aris Angelis, Frederick R Appelbaum, et al.
The Journal of Clinical Investigation|June 12, 2020
Early safety indicators of COVID-19 convalescent plasma in 5000 patientsMichael J Joyner, R Scott Wright, DeLisa Fairweather, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasmaJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
The New England Journal of Medicine|February 1, 2021
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19Michael J Joyner, Rickey E Carter, Jonathon W Senefeld, et al.
Brain : a Journal of Neurology|February 9, 2021
An ancestral 10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathyAlistair T Pagnamenta, Rauan Kaiyrzhanov, Yaqun Zou, et al.
Mayo Clinic Proceedings|August 31, 2020
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized PatientsMichael J Joyner, Katelyn A Bruno, Stephen A Klassen, et al.
Nature Communications|August 12, 2021
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donorsKatie L Kunze, Patrick W Johnson, Noud van Helmond, et al.
Plos Medicine|December 20, 2021
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry studyJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Molecular Therapy. Methods & Clinical Development|August 11, 2021
Evidence generation and reproducibility in cell and gene therapy research: A call to actionMohamed Abou-El-Enein, Aris Angelis, Frederick R Appelbaum, et al.
The Journal of Clinical Investigation|June 12, 2020
Early safety indicators of COVID-19 convalescent plasma in 5000 patientsMichael J Joyner, R Scott Wright, DeLisa Fairweather, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasmaJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
The New England Journal of Medicine|February 1, 2021
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19Michael J Joyner, Rickey E Carter, Jonathon W Senefeld, et al.
Brain : a Journal of Neurology|February 9, 2021
An ancestral 10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathyAlistair T Pagnamenta, Rauan Kaiyrzhanov, Yaqun Zou, et al.
Mayo Clinic Proceedings|August 31, 2020
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized PatientsMichael J Joyner, Katelyn A Bruno, Stephen A Klassen, et al.
Nature Communications|August 12, 2021
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donorsKatie L Kunze, Patrick W Johnson, Noud van Helmond, et al.
Plos Medicine|December 20, 2021
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry studyJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
Pageof 7